Clinical Trials Directory

Trials / Completed

CompletedNCT05851820

Prevalence and Impact of Diabetes Mellitus in Hospitalized COVID-19 Patients in a Tunisian Center

Prevalence and Impact of Diabetes Mellitus in Hospitalized COVID-19 Patients in a Tunisian Center: a Cross Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
866 (actual)
Sponsor
Sana Rouis · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Objective: The objective of this study was to evaluate the prevalence and impact of diabetes mellitus on the severity and mortality of COVID-19. Methods: Data of laboratory-confirmed hospitalized patients at the COVID-19 unit of Ibn El Jazzar University Hospital in Kairouan between September 2020 and August 2021 were analysed, in a cross-sectional study. The population was classified into two groups (COVID-19 patients with versus without diabetes). Primary outcomes were the overall length of hospital stay, the admission to the intensive care unit (ICU), and death.

Detailed description

The outbreak of the coronavirus disease 2019 (Covid-19) has become an evolving worldwide health crisis. With the rising prevalence of diabetes mellitus has come an increasing awareness of their impacts on infectious diseases, and the risk for post-infection complications and mortality from critical infections. Objective: The objective of this study was to evaluate the prevalence and impact of diabetes mellitus on the severity and mortality of COVID-19. Methods: Data of laboratory-confirmed hospitalized patients at the COVID-19 unit of Ibn El Jazzar University Hospital in Kairouan between September 2020 and August 2021 were analysed, in a cross-sectional study. The population was classified into two groups (COVID-19 patients with versus without diabetes). Primary outcomes were the overall length of hospital stay, the admission to the intensive care unit (ICU), and death. Association between diabetes and death was assessed in a Cox proportional hazards model.

Conditions

Interventions

TypeNameDescription
OTHERcomparison of outcomes/exposureanalysing if diabetes mellitus have an impact on the primary outcomes: hospital stay, admission to the ICU, death.

Timeline

Start date
2020-09-25
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2023-05-10
Last updated
2023-05-10

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT05851820. Inclusion in this directory is not an endorsement.